1.Living with COVID-19: The road ahead.
Wycliffe Enli WEI ; Wei Keat TAN ; Alex Richard COOK ; Li Yang HSU ; Yik Ying TEO ; Vernon Jian Ming LEE
Annals of the Academy of Medicine, Singapore 2021;50(8):619-628
INTRODUCTION:
The COVID-19 pandemic has affected the world for more than a year, with multiple waves of infections resulting in morbidity, mortality and disruption to the economy and society. Response measures employed to control it have generally been effective but are unlikely to be sustainable over the long term.
METHODS:
We examined the evidence for a vaccine-driven COVID-19 exit strategy including academic papers, governmental reports and epidemiological data, and discuss the shift from the current pandemic footing to an endemic approach similar to influenza and other respiratory infectious diseases.
RESULTS:
A desired endemic state is characterised by a baseline prevalence of infections with a generally mild disease profile that can be sustainably managed by the healthcare system, together with the resumption of near normalcy in human activities. Such an endemic state is attainable for COVID-19 given the promising data around vaccine efficacy, although uncertainty remains around vaccine immunity escape in emergent variants of concern. Maintenance of non-pharmaceutical interventions remains crucial until high vaccination coverage is attained to avoid runaway outbreaks. It may also be worthwhile to de-escalate measures in phases, before standing down most measures for an endemic state. If a variant that substantially evades immunity emerges, it will need to be managed akin to a new disease threat, with pandemic preparedness and response plans.
CONCLUSION
An endemic state for COVID-19, characterised by sustainable disease control measures, is likely attainable through vaccination.
COVID-19
;
Disease Outbreaks/prevention & control*
;
Humans
;
Influenza, Human/prevention & control*
;
Pandemics/prevention & control*
;
SARS-CoV-2
2.Research on COVID-19 vaccination strategies in Singapore.
He Ya YI ; Jie Mi ZHAO ; Xiao Feng LIANG ; Teo Yik YING
Chinese Journal of Epidemiology 2022;43(3):310-314
As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China.
COVID-19/prevention & control*
;
COVID-19 Vaccines
;
Humans
;
Immunization Programs
;
Singapore
;
Vaccination